受强制性开放获取政策约束的文章 - Motao Zhu了解详情
无法在其他位置公开访问的文章：6 篇
A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy
Y Tian, S Li, J Song, T Ji, M Zhu, GJ Anderson, J Wei, G Nie
Biomaterials 35 (7), 2383-2390, 2014
强制性开放获取政策： National Health and Medical Research Council, Australia
Biomembrane-based nanostructures for cancer targeting and therapy: from synthetic liposomes to natural biomembranes and membrane-vesicles
J Wang, M Zhu, G Nie
Advanced drug delivery reviews 178, 113974, 2021
强制性开放获取政策： 中国科学院, 国家自然科学基金委员会
Nanotechnology-empowered vaccine delivery for enhancing CD8+ T cells-mediated cellular immunity
G Liu, M Zhu, X Zhao, G Nie
Advanced drug delivery reviews 176, 113889, 2021
强制性开放获取政策： 中国科学院, 国家自然科学基金委员会
Use of nanoformulation to target macrophages for disease treatment
X Liu, X Xie, J Jiang, M Lin, E Zheng, W Qiu, I Yeung, M Zhu, Q Li, T Xia, ...
Advanced Functional Materials 31 (38), 2104487, 2021
强制性开放获取政策： 中国科学院
Commensal bacterial hybrid nanovesicles improve immune checkpoint therapy in pancreatic cancer through immune and metabolic reprogramming
G Liu, W Huang, L Chen, N Tayier, L You, M Hamza, X Tian, H Wang, ...
Nano Today 52, 101993, 2023
强制性开放获取政策： 中国科学院, 国家自然科学基金委员会
The potential of nano-enabled oral ecosystem surveillance for respiratory disease management
Y Shi, L Chen, H Zhang, G Nie, Z Zhang, M Zhu
Nano Today 48, 101693, 2023
强制性开放获取政策： 中国科学院
可在其他位置公开访问的文章：16 篇
Physicochemical properties determine nanomaterial cellular uptake, transport, and fate
M Zhu, G Nie, H Meng, T Xia, A Nel, Y Zhao
Accounts of chemical research 46 (3), 622-631, 2013
强制性开放获取政策： US National Institutes of Health
Safety of nanoparticles in medicine
J Wolfram, M Zhu, Y Yang, J Shen, E Gentile, D Paolino, M Fresta, G Nie, ...
Current drug targets 16 (14), 1671-1681, 2015
强制性开放获取政策： US National Institutes of Health, 国家自然科学基金委员会
Applications of nanomaterials as vaccine adjuvants
M Zhu, R Wang, G Nie
Human vaccines & immunotherapeutics 10 (9), 2761-2774, 2014
强制性开放获取政策： 国家自然科学基金委员会
Microbiota regulate innate immune signaling and protective immunity against cancer
C Xing, M Wang, AA Ajibade, P Tan, C Fu, L Chen, M Zhu, ZZ Hao, J Chu, ...
Cell host & microbe 29 (6), 959-974. e7, 2021
强制性开放获取政策： US Department of Defense, US National Institutes of Health
Cell-penetrating nanoparticles activate the inflammasome to enhance antibody production by targeting microtubule-associated protein 1-light chain 3 for degradation
M Zhu, L Du, R Zhao, HY Wang, Y Zhao, G Nie, RF Wang
ACS nano 14 (3), 3703-3717, 2020
强制性开放获取政策： US Department of Defense, US National Institutes of Health
Inflammasome activation negatively regulates MyD88-IRF7 type I IFN signaling and anti-malaria immunity
X Yu, Y Du, C Cai, B Cai, M Zhu, C Xing, P Tan, M Lin, J Wu, J Li, M Wang, ...
Nature communications 9 (1), 4964, 2018
强制性开放获取政策： US Department of Defense, US National Institutes of Health, 国家自然科学基金 …
Co-delivery of tumor antigen and dual toll-like receptor ligands into dendritic cell by silicon microparticle enables efficient immunotherapy against melanoma
M Zhu, X Ding, R Zhao, X Liu, H Shen, C Cai, M Ferrari, HY Wang, ...
Journal of Controlled Release 272, 72-82, 2018
强制性开放获取政策： US Department of Defense, US National Institutes of Health
Biomimetic and bioinspired nano‐platforms for cancer vaccine development
C Feng, P Tan, G Nie, M Zhu
Exploration 3 (3), 20210263, 2023
强制性开放获取政策： 中国科学院
Myeloid loss of Beclin 1 promotes PD-L1hi precursor B cell lymphoma development
P Tan, L He, C Xing, J Mao, X Yu, M Zhu, L Diao, L Han, Y Zhou, MJ You, ...
The Journal of clinical investigation 129 (12), 5261-5277, 2022
强制性开放获取政策： US Department of Defense, US National Institutes of Health, Cancer …
Nanomedicine targets iron metabolism for cancer therapy
L Lin, H Chen, R Zhao, M Zhu, G Nie
Cancer Science 113 (3), 828-837, 2022
强制性开放获取政策： 国家自然科学基金委员会
Beclin 2 negatively regulates innate immune signaling and tumor development
M Zhu, G Deng, P Tan, C Xing, C Guan, C Jiang, Y Zhang, B Ning, C Li, ...
The Journal of clinical investigation 130 (10), 5349-5369, 2020
强制性开放获取政策： US Department of Defense, US National Institutes of Health, Cancer …
BECN2 (beclin 2) negatively regulates inflammasome sensors through ATG9A-dependent but ATG16L1-and LC3-independent non-canonical autophagy
G Deng, C Li, L Chen, C Xing, C Fu, C Qian, X Liu, HY Wang, M Zhu, ...
Autophagy 18 (2), 340-356, 2022
强制性开放获取政策： US Department of Defense, US National Institutes of Health, Cancer …
BECN2 (beclin 2)-mediated non-canonical autophagy in innate immune signaling and tumor development
M Zhu, G Deng, C Xing, G Nie, RF Wang
Autophagy 16 (12), 2310-2312, 2020
强制性开放获取政策： US Department of Defense, US National Institutes of Health
USP3 plays a critical role in the induction of innate immune tolerance
T Duan, Y Feng, Y Du, C Xing, J Chu, J Ou, X Liu, M Zhu, C Qian, B Yin, ...
EMBO reports 24 (12), e57828, 2023
强制性开放获取政策： US Department of Defense, US National Institutes of Health, 国家自然科学基金 …
出版信息和资助信息由计算机程序自动确定